Uterine adenosarcomas: A dual-institution experience
Erişim
info:eu-repo/semantics/closedAccessTarih
2017Yazar
Özgü, EmreNarin, Mehmet Ali
Yalçın, Hakan Raşit
Taşçı, Tolga
Güngör, Tayfun
Çavuşoğlu, Deniz
Meydanlı, Mehmet Mutlu
Tulunay, Gökhan
Üst veri
Tüm öğe kaydını gösterKünye
Özgü, E., Narin, M. A., Yalçın, H. R., Taşçı, T., Güngör, T., Çavuşoğlu, D., ... & Tulunay, G. (2017). Uterine adenosarcomas: A dual-institution experience. Journal of Obstetrics and Gynaecology, 37(1), 93-96.Özet
There has been limited literature about treatment and follow-up strategies of uterine adenosarcomas because of their rare nature. For this study we retrospectively investigated the medical database of the two major womens’ health hospitals in Turkey. A total of 15 patients were identified from the hospital’s database. Median follow-up was 86.43 months for all patients. Seven out of 15 patients had recurrences during their follow-up. Among these 7 patients, 4 of them had stage IA disease. Median Disease Free Survival (DFS) and Overall Survival (OS) were calculated as 41.47 and 57.21 months, respectively. According to our study, polypoid tumours confined to the uterus with superficial myometrial invasion can be treated without comprehensive surgical staging. We believe that, publishing all the data in an organised manner even though they are small in size, gives us an opportunity to design meta-analysis for the development of more appropriate treatment strategies. © 2016 Informa UK Limited, trading as Taylor & Francis Group.
Kaynak
Journal of Obstetrics and GynaecologyCilt
37Sayı
1Koleksiyonlar
- Makale Koleksiyonu [524]
- Scopus İndeksli Yayınlar Koleksiyonu [2695]
- WoS İndeksli Yayınlar Koleksiyonu [2986]